Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
NCT02407496 is an observational study sponsored by Think Now Incorporated. As of 21 Nov 2026, it is completed. It studies Attention Deficit Hyperactivity Disorder (ADHD). The registry lists an enrollment of 80 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2014 and a primary completion date of 31 Jul 2015.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02407496 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Think Now Incorporated |
| Enrollment | 80 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Attention Deficit Hyperactivity Disorder (ADHD) |
| Start | 30 Jun 2014 |
| Primary completion | 31 Jul 2015 |
| Study completion | 30 Sept 2015 |
| Last update posted | 10 Dec 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gregory V Simpson, Ph.D.
Think Now, Inc.
Principal Investigator - Mark S Cohen, Ph.D.
University of California, Los Angeles
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Semel Institute
Los Angeles
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02407496
Each answer restates registry values shown on this page.
What is NCT02407496?
NCT02407496 is an observational study sponsored by Think Now Incorporated. It studies Attention Deficit Hyperactivity Disorder (ADHD).
Who leads NCT02407496?
The registry names Gregory V Simpson, Ph.D. (principal investigator, Think Now, Inc.) and Mark S Cohen, Ph.D. (study director, University of California, Los Angeles) as overall officials.
Where does NCT02407496 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02407496 end?
The registry lists a primary completion date of 31 Jul 2015 and a study completion date of 30 Sept 2015. The sponsor last updated the record on 10 Dec 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.